Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04432805
Other study ID # 2020-30
Secondary ID 2020-A01303-36
Status Terminated
Phase N/A
First received
Last updated
Start date October 13, 2020
Est. completion date January 2, 2021

Study information

Verified date August 2022
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cohort prospective study. Objectives : Primary objective: To describe the lung ultrasound lesions in pregnant women in case of suspected or confirmed COVID-19 Secondary objectives: - To compare the lung ultrasound lesions with chest Computed Tomography -scanner (CT-Scan) lesions - To evaluate the performances of the lung ultrasound to diagnose COVID-19 in pregnant women - To evaluate predictive value of different lung ultrasound lesions for intensive care unit admission of pregnant women with suspected or confirmed COVID-19 - To describe the pregnancy issues of the study population Course of the study: - Inclusion of pregnant suspected of having COVID-19 and cared following the service protocol - Performing of lung ultrasound at bedside in labor ward or in COVID unit Primary outcome: Lung ultrasound lesions (and corresponding score) at the moment of the initial management of pregnant women suspected or confirmed with COVID-19 (having a nasopharyngeal Reverse Transcription Polymerase Chain Reaction (RT-PCR) SARS-CoV-2 and a chest CT-scan)


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date January 2, 2021
Est. primary completion date January 2, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age greater than or equal to 18 years - Gestational age greater than or equal to 22 weeks of gestation - Pregnant women suspected of COVID-19 : - already having a nasopharyngeal RT-PCR for the SARS-CoV-2 - AND having a chest CT-scan or waiting for this exam - Women giving a writing consent to participate Exclusion Criteria: - Women giving an opposition to participate - Women not enough fluent in French to benefit from clear and intelligible information

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Performing of lung ultrasound
Performing of lung ultrasound at bedside in labor ward or in COVID unit

Locations

Country Name City State
France Assistance Publique Hôpitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Description of the lesions Description of the lesions in each of the 6 pulmonary quadrants on the right and left. Establishment of the ultrasound score corresponding to the sum of the scores attributed to each type of lesion in each quadrant (0: normal, 1: spaced comet tails, 2: curtain comet tails, 3: consolidation). 4 months